文献速递药物不良反应与药物警戒

提升欧盟监管网络药物警戒能力:SCOPE联合行动

Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action.
PubMed 文献 · Drug Saf · 2018-01-01

该项目评估成员国现行药物警戒实践,开发工具以提升网络技能和能力,并交付指导、培训及工具模板,支持国家系统强化。

要点

  • SCOPE项目评估成员国药物警戒实践并开发改进工具。
  • 项目分八个工作流,五个聚焦药物警戒主题,三个聚焦功能方面。
  • 交付物包括指导、培训及工具模板,可供多利益相关方使用。

核心结论

  • SCOPE联合行动通过评估现行实践和开发工具,提升了欧盟药物警戒网络的技能和能力。

研究设计与样本

  • 项目分为八个工作流,五个聚焦药物警戒主题,三个聚焦功能方面。

主要发现

  • SCOPE收集了成员国运行国家药物警戒系统的信息和专业知识,以符合2012年6月生效的药物警戒立法要求。
  • 项目评估了当时的实践,并开发了进一步改进药物警戒网络技能和能力的工具。

临床怎么用

  • 欧洲国家主管当局工作人员可利用SCOPE交付的实践指导来加强国家系统。
  • SCOPE产出可供制药行业、医疗专业人员、患者和消费者组织及学术界等其他利益相关方使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In November 2013, a team of European regulators initiated the Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action. Funded by the Health Programme of the European Union, and with contributions from the involved Member States, SCOPE gathered information and expertise on how regulators in Member States run their national pharmacovigilance systems to meet the requirements of the pharmacovigilance legislation that came into effect in June 2012. The SCOPE project evaluated then-current practices and developed tools to further improve the skills and capability in the pharmacovigilance network. The project was divided into eight separate work streams, five of which concentrated on pharmacovigilance topics-collecting information on suspected adverse drug reactions, identifying and managing safety issues (signals), communicating risk and assessing risk minimisation measures, supported by effective quality management systems. The other three work streams focused on the functional aspects-coordination, communication and evaluation of the project. Through the project, SCOPE delivered guidance, training in key aspects of pharmacovigilance, and tools and templates to support best practice. The deliverables provide practical guidance that those working in the European national competent authorities can take to strengthen their national systems. The SCOPE outputs can be useful for other stakeholders involved in pharmacovigilance activities, including the pharmaceutical industry, healthcare professionals, patient and consumer organisations, and academia.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Radecka A, Loughlin L, Foy M, et al. Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action. Drug Saf. 2018. PMID: 30128638. doi:10.1007/s40264-018-0708-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。